Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence in Patients Diagnosed With Early-stage Breast Cancer and Ovarian Cancer in Remission
Phase: PHASE1 | Sponsor: University of Colorado, Denver | Compound: Psilocybin
- Status
- recruiting
- Institution
- University of Colorado, Denver
- Start date
- 2024-11-21
- End date
- 2028-12-01
- Registry ID
- NCT06430541
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.